Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001047469-16-016307
Filing Date
2016-10-26
Accepted
2016-10-26 16:01:27
Documents
10
Effectiveness Date
2016-10-26

Document Format Files

Seq Description Document Type Size
1 S-3ASR a2230096zs-3asr.htm S-3ASR 274314
2 EX-4.5 a2230096zex-4_5.htm EX-4.5 596961
3 EX-5.1 a2230096zex-5_1.htm EX-5.1 53255
4 EX-5.2 a2230096zex-5_2.htm EX-5.2 32276
5 EX-12.1 a2230096zex-12_1.htm EX-12.1 47013
6 EX-23.1 a2230096zex-23_1.htm EX-23.1 3063
7 EX-25.1 a2230096zex-25_1.htm EX-25.1 132701
8 G7385.JPG g7385.jpg GRAPHIC 25754
9 G198222KGI001.JPG g198222kgi001.jpg GRAPHIC 3721
10 G198222KII001.GIF g198222kii001.gif GRAPHIC 4455
  Complete submission text file 0001047469-16-016307.txt   1187811
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-214257 | Film No.: 161952657
SIC: 2834 Pharmaceutical Preparations